Kobe, Japan

Mami Onishi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Sysmex Corporation. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mami Onishi: Innovator in Cardiovascular Disease Risk Assessment

Introduction

Mami Onishi is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of cardiovascular health through her innovative research and patent development. Her work focuses on methods for assessing the risk of cardiovascular diseases, which is crucial for early intervention and treatment.

Latest Patents

Mami Onishi holds a patent for a method that determines the onset risk of cardiovascular disease in a subject. This patent, titled "Method for determining onset risk of cardiovascular disease in subject, and method for determining vascular calcification in subject," outlines a novel approach to evaluating cardiovascular health. The method aims to provide healthcare professionals with valuable insights into a patient's risk factors, enabling more effective management of cardiovascular conditions. She has 1 patent to her name.

Career Highlights

Mami Onishi is currently employed at Sysmex Corporation, a leading company in the field of medical diagnostics. Her role at Sysmex allows her to apply her expertise in developing innovative solutions for cardiovascular health. Throughout her career, she has demonstrated a commitment to advancing medical technology and improving patient outcomes.

Collaborations

Mami has collaborated with notable colleagues, including Maria Kiriyama and Eiya Tamada. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the medical field.

Conclusion

Mami Onishi's contributions to cardiovascular disease risk assessment highlight her dedication to innovation and healthcare improvement. Her patent and work at Sysmex Corporation exemplify the importance of research in developing effective medical solutions. Through her efforts, she continues to make a significant impact on the field of cardiovascular health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…